文献速递血液透析通路

血液透析动静脉瘘/移植物创建同期联合流出道静脉腔内矫正的杂交手术

Creation of Arteriovenous Fistulas and Grafts Concomitantly with Endovascular Correction of Outflow Veins: A Hybrid Procedure.
PubMed 文献 · Ann Vasc Surg · 2019-07-31

本研究回顾了15例透析年限长且既往通路手术多的患者,在创建透析瘘的同时行流出道静脉腔内矫正。杂交手术12个月和24个月一期通畅率分别为72.7%和63.6%,无早期并发症,表明该杂交术式可为血管条件复杂的患者建立功能良好的透析通路。

要点

  • 杂交手术同期矫正流出道静脉病变,可为血管条件复杂患者创建功能良好的透析瘘。
  • 12个月和24个月一期通畅率分别为72.7%和63.6%。
  • 无与腔内或开放手术相关的早期并发症。

核心结论

  • 杂交手术创建透析瘘并同期矫正流出道病变,可获得功能良好的透析瘘,适用于血管条件复杂的患者。

研究设计与样本

  • 回顾性观察研究,2014年1月1日至2018年6月30日共纳入15例同期行透析瘘创建与流出道腔内矫正的患者。
  • 患者透析史中位10.5年(范围3-22),既往透析通路手术平均5.3次(范围2-9)。
  • 对照包括标准移动脉-头静脉透析瘘创建组(RCAVF组,65例)和透析瘘狭窄血管成形术组(PTA组,30例)。
  • 中位随访18个月。

主要发现

  • 13例(86.7%)瘘建于上臂;5例(33.3%)使用聚四氟乙烯(PTFE)人工血管,另3例用PTFE延伸静脉;7例(46.7%)为自体血管瘘。
  • 腔内矫正的静脉包括锁骨下静脉8例(53.3%)、头臂静脉6例(40.0%)、头静脉/贵要静脉/腋静脉各2例(13.3%)、上腔静脉1例(6.7%)。
  • 杂交手术瘘12个月和24个月一期通畅率分别为72.7%和63.6%。
  • 未观察到与腔内或开放手术相关的早期并发症。

临床怎么用

  • 对于血管条件复杂、既往通路手术多的透析患者,可考虑杂交手术同期创建透析瘘并矫正流出道静脉病变。

局限性

  • 样本量小(15例),为单中心回顾性研究,随访时间有限(中位18个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Achieving well-functioning dialysis fistulas is a common problem in dialyzed patients, and it is mainly caused by the pathologies of vessels used for fistula creation. Hybrid therapies, combining surgical and endovascular procedures, potentially enable the creation of functional dialysis fistulas in patients with vessels that are otherwise unsuitable for vascular access. METHODS: Between January 1, 2014 and June 30, 2018, we created dialysis fistulas simultaneously with endovascular correction of outflow pathologies in 15 patients. The included patients had a long history of dialysis (median 10.5 years, range 3-22) and many previous dialysis access procedures (mean 5.3 procedures, range 2-9). In 13 patients (86.7%), the fistula was created on the upper arm; in 5 patients (33.3%), it was arteriovenous graft done with polytetrafluoroethylene (PTFE) prosthesis (in an additional 3 patients, a PTFE prosthesis was used to extend the vein), and 7 patients had native vessel fistulas (46.7%). Endovascular procedures, in some cases performed on more than 1 vein, were applied for correction of the subclavian vein (8 patients, 53.3%); brachiocephalic vein (6 patients, 40.0%); cephalic, basilic, and axillary veins (2 patients each, 13.3%); and superior cava vein (1 patient, 6.7%). Access for the endovascular procedure was achieved through a dissected vein used for arteriovenous anastomosis. The fistula function was monitored, and all complications of dialysis access were noted. The median follow-up in the observed group was 18 months. We compared the patency of dialysis fistula creation combined with endovascular correction of outflow vein pathology to our results of standard dialysis fistula operations: radiocephalic dialysis fistula creation (RCAVF group, 65 patients) and dialysis fistula stenosis angioplasty (PTA group, 30 patients). RESULTS: The 12- and 24-month primary patency rates of dialysis fistulas created in hybrid procedures with simultaneous outflow vein pathology correction were 72.7% and 63.6%, respectively. No early complications related to endovascular or open procedures were observed. CONCLUSIONS: A hybrid procedure for the creation of a dialysis fistula with the simultaneous correction of outflow pathologies enables a properly functioning dialysis fistula to be obtained. This procedure can be performed in patients with complicated vascular situations, enabling the creation of dialysis fistulas. Our results of hybrid procedures, involving simultaneous endovascular correction of the outflow vein with dialysis fistula creation, showed the efficiency and good results.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Szewczyk D, Bojakowski K, Kasprzak D, et al. Creation of Arteriovenous Fistulas and Grafts Concomitantly with Endovascular Correction of Outflow Veins: A Hybrid Procedure. Ann Vasc Surg. 2019. PMID: 31376541. doi:10.1016/j.avsg.2019.04.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。